22.04.2014 Views

Development of novel formulations for mucosal delivery of protein ...

Development of novel formulations for mucosal delivery of protein ...

Development of novel formulations for mucosal delivery of protein ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

male wistar rats after induction <strong>of</strong> colitis disintegrated specifically in the large intestines as<br />

compared to the control <strong>for</strong>mulation (absence <strong>of</strong> chitosan) which demonstrated absorption <strong>of</strong><br />

the drug in the small intestines.<br />

Chitosan has mucoadhesive properties and is <strong>of</strong>ten exploited to enhance the residence<br />

time <strong>of</strong> a drug on the <strong>mucosal</strong> membrane thereby increasing the drug bioavailability. A<br />

comparison between chitosan and other commonly used polymeric excipients indicates that<br />

the cationic polymer has higher bioadhesivity compared to other natural polymers, such as<br />

cellulose, xanthan gum, and starch (Kotze et al., 1999).<br />

1.6.2 Pharmaceutical and medicinal uses <strong>of</strong> chitosan<br />

A number <strong>of</strong> clinical studies have reported the use <strong>of</strong> chitosan as cell scaffolds in<br />

tissue engineering, nerve regeneration tubes, and cartilage regeneration (Khor & Lim, 2003,<br />

Freier et al., 2005, Mwale et al., 2005). In addition, it has been used extensively as a<br />

biomaterial, owing to its immunostimulatory activities (Gorbach et al., 1994), anticoagulant<br />

properties, antimicrobial and antifungal action (Rabea et al., 2003) and <strong>for</strong> its action as a<br />

promoter <strong>of</strong> wound healing in the field <strong>of</strong> surgery (Khan et al., 2000). Because <strong>of</strong> its<br />

biocompatibility and biodegradation properties (Vandevord et al., 2002), chitosan has been<br />

used in a variety <strong>of</strong> pharmaceutical <strong><strong>for</strong>mulations</strong>, primarily <strong>for</strong> the purpose <strong>of</strong> controlled drug<br />

<strong>delivery</strong> (Agnihotri et al., 2004), such as <strong>mucosal</strong> (Illum et al., 2001, Van Der Lubben et al.,<br />

2001, Read et al., 2005), buccal (Giunchedi et al., 2002), and ocular (De Campos et al., 2004)<br />

<strong>delivery</strong> <strong>of</strong> drugs.<br />

Due to its cationic nature, chitosan is capable <strong>of</strong> opening tight junctions in a cell<br />

membrane. This property has led to a number <strong>of</strong> studies to investigate the use <strong>of</strong> chitosan as a<br />

permeation enhancer <strong>for</strong> hydrophilic drugs such as peptides that may otherwise have poor oral<br />

bioavailability (Thanou et al., 2000). Because the absorption enhancement is caused by<br />

interactions between the cell membrane and positive charges on the polymer, the phenomenon<br />

is pH and concentration dependant. Furthermore, increasing the charge density on the<br />

polymer would lead to higher permeability. This has been studied by quaternizing the amine<br />

functionality on chitosan (Hamman et al., 2003). The amine functionality is further explored<br />

in the proceeding section.<br />

30

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!